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Abstract 
Typhoid fever has remained endemic and a major health problem in developing countries like Kenya due to poor 
sanitation, overcrowding and limited access to diagnostic services. The main aim of this study was to determine 
the diagnostic value of TUBEX® TF IGM antibody tests for early diagnosis of typhoid fever among hospitalized 
patients in Nairobi County. TUBEX® TF is a competitive immunoassay which detects presence of anti-09 IgM 
Salmonella Typhi antibodies in a patient’s serum. We studied TUBEX® TF a rapid sera diagnostic test for its 
usefulness in early diagnosis of typhoid fever and we compared its sensitivity and specificity to that of Widal test.  
The study was conducted on 92 (Gp-I) febrile patients who had clinically suggestive signs and symptoms of 
typhoid fever. Two groups of controls were created; 45 (Gp-II) and 15 (Gp-III) age and sex matched febrile and 
healthy controls, respectively.  Blood culture was performed in all cases while TUBEX® TF and Widal tests were 
performed in both cases and controls. The sample size was based on convenience at the two health facilities of our 
study. Gp-I had 9 (9.78%) blood culture positives for S.Typhi, 11(11.99%) were positive for TUBEX® TF while 
17 (18.48%) were positive for Widal test. 3 (6.67%) Gp-II were positive on both TUBEX® TF and Widal test while 
none of the two tests tested positive on Gp-III. Among 9 culture positive cases, TUBEX® TF was positive in 8 
cases same as Widal test with sensitivity, specificity, PPV and NPV values of 88.9% (95% CI: 51.18-99.7), 97.6% 
(95% CI: 91.6-99.7), 80.0 %(95% CI: 44.4-97.5), 98.8 %(95% CI: 93.4-100), respectively. Widal test had 88.89% 
(95% CI: 51.8-99.7), 90.4% (95% CI: 81.9-95.7), 50.00% (95% CI: 24.7-75.3), 98.7% (95% CI: 92.9-100) 
respectively. This study demonstrated better results with TUBEX® TF test compared to Widal test when blood 
culture was used as a gold standard. However, these results should be further confirmed by using multiple gold 
standard tests such as molecular and enzyme-linked immunosorbent assays and carried out on large scale cross-
sectional studies with varied prevalence of typhoid fever in the population.  
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1. Introduction  
Enteric fever, an infection caused by Salmonella enterica serovar Typhi and serovar Paratyphi A remains a major 
public health challenge. The occurrence of enteric fever in poor populations with limited access to diagnostic 
services means that the disease burden is poorly quantified (WHO, 2003). It is estimated that by the year 2000, 
typhoid fever had caused 21.6 million illnesses and 216, 500 deaths globally (Crump et al., 2004). It has continued 
to be a major cause of morbidity, particularly in children and young adults in South East Asia, although accurate 
assessments are still hindered by the lack of reliable surveillance data (Darton et al., 2014). In Africa, Crump et 
al., 2004 estimates incidence of typhoid infections of 10-100 cases/100, 000 person years in most African countries, 
with the incidence highest in childhood. In East Africa, the incidence was estimated at 39/100, 000 person years. 
The high rate of infection and dominance of paratyphoid fever in several geographical areas in Africa are of 
particular concern (Darton et al., 2014). The global concern in Kenya is reflected in perceptions that typhoid is a 
common and serious disease among children and adults, where highly publicized outbreaks have strengthened this 
view among the public and health professionals (Mweu et al., 2008). The use of Widal test has strengthened this 
concern for it is the rapid test mostly performed in most primary health settings and inability of these settings to 
perform blood culture (Willke et al., 2002).  This is because the frequent use of Widal test is not only unlikely to 
be helpful but can also be misleading resulting to misdiagnosis and worsening antibiotic resistance (Mweu et al., 
2008). Therefore, accurate diagnosis of enteric fever has remained a challenge due to the nonspecific clinical 
presentation of cases and the low sensitivity and specificity of the commonly available tests (Darton et al., 2014). 
The control strategies utilizing cheap accurate diagnostics and effective vaccines are urgently required, and their 
development should be accelerated by the use of a human challenge model (Bhutta, Z.A, 2006).  There have been 
few attempts to establish simple clinical case definitions for typhoid fever to help in case identification at 
presentation to health facilities (Tam et al., 2003).  
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For effective management of disease, there is a need for better data on typhoid fever among hospitalized 
patients. This data would be best generated by effective, broadly hospital based systems that could capture data on 
a range of serious bacterial diseases in urban and rural settings. Few or no such systems exist in the poorer countries 
of Africa and Asian countries where disease burdens are the highest (Mweu et al., 2008). Missed diagnoses and 
worsening antibiotic resistance may result, although the higher prevalence of non-typhoidal Salmonellae (NTS) 
makes it likely that on some occasions a child falsely diagnosed as having typhoid will by chance receive 
appropriate treatment for NTS (Graham SM., 2002). While newer, improved diagnostics are therefore urgently 
required, it is clear that they will have to be highly sensitive and specific (>90%) serological tests (Mweu et al., 
2008). 
Serologic laboratory testing of typhoid fever is important and can be a very useful complement to blood 
culture in order to increase the clinical information.  This prospective validation study sought to evaluate the 
performance of rapid point of care diagnostic test TUBEX® TF for rapid detection of anti-Salmonella Typhi 
antibody test for early diagnosis of typhoid fever among hospitalized well-defined cohorts at Mbagathi County 
and Kenyatta National hospitals and selected control subjects to give a better sensitivity and specificity results for 
the TUBEX® TF kit. The core objective of this study was exhaustively met. 
 
2. Materials and Methods 
2.1 Study Participants and Sample Collection 
Patients were recruited from two hospitals: Mbagathi County and Kenyatta National hospitals in Nairobi County, 
Kenya. The study took place between the period of January, 2018 and July, 2018. Majority of the patients 
presenting at these hospitals came from the neighboring informal settlement, Kibera. We obtained blood from 
consecutive clinically suspected typhoid fever cases, febrile patients and healthy individuals. Those that fulfilled 
criteria for suspected typhoid fever case had ≥37.5°C axillary temperature, abdominal pain, headache, constipation, 
diarrhea, vomiting, rash and who reported not to have taken antibiotic in the last 1 to > 2 days. All the patients 
were briefed on the significance and the aim of the study before they gave both oral and written informed consent. 
They were also asked to answer a brief questionnaire on clinical symptoms, vaccination history and antimicrobial 
use on a patient history form. Blood samples were drawn aseptically for blood culture following serological sample 
collection. For children 5-12 years of age, up to 5mls of blood was collected, 1- 3mls of this was inoculated 
immediately into a BACTEC Ped Plus/F (enriched Soybean-casein digest broth with CO2; Becton-Dickenson) 
blood culture bottle (for children) while 2mls was put in plain vacutainer tube. For participants ≥ 13 years, we 
attempted to collect 8-10mls of blood, which was placed into a BACTEC Plus/F (for adults) bottle. Blood and 
broth were made to mix by inverting the inoculated bottles 4-5 times.  
The collected samples were coded for reference in the laboratory for testing. Blood samples were then 
transported from the respective hospitals to the laboratories at the Center for Microbiology Research (CMR) at 
Kenya Medical Research Institute (KEMRI) while placed in a cooler box. Upon receipt at the laboratory, 
inoculated BACTEC Plus/F bottles were placed into BACTEC™ 9050(Becton, Dickinson and Company) blood 
culture system while vacutainer tubes containing blood for serology were centrifuged at 3000 x g for 10 minutes. 
The serum aliquots were separated from whole blood and placed in cryotubes then stored at -20O C for later 
serological testing. 
 
2.2 Laboratory Methods Performed  
2.2.1 Blood Culture  
Blood placed in BACTEC™ 9050 were incubated at 370C for seven days or until growth was observed through 
the Bactec automated signal according to the current standard operating procedures of the Kenya Research Institute 
(KEMRI).  The positive samples were then subcultured on MacConkey agar and blood agar. Suspected colonies 
for S. Typhi were identified by Gram stain, standard biochemical tests including Oxidase test, Triple test sugar-
iron sugar agar (TSI), Urease, motility test, Citrate and Indole and agglutination test with Salmonella-specific 
antisera 
2.2.2 TUBEX® TF Test 
All analysis using TUBEX® TF and blood culture were performed according to instruction for use as supplied 
together with the kit (http://www.idl.se). TUBEX® TF is a semi quantitative colorimetric test that detects titers of 
Salmonella enterica serovar Typhi lipopolysaccharide (LPS) O9 antigens in patient serum (Tam et al., 2003). It 
was run in parallel and independently with blood culture and processed on a blinded basis according to 
manufacturer’s instructions, with the operator unaware of the result from blood culture and status of the patients. 
The score range from 0 (clear pink) to 10 (intense blue). Interpretation of TUBEX® test was done by at least 3 
independent observers (The PI and 2 qualified technical persons) to validate the results. 2 out of 3 concordant 
results were recorded as either negative or positive with corresponding semi quantitative scores using the magnetic 
color scale. The score of 0-2 was interpreted as negative while the score of ≥ 4 was interpreted as positive TUBEX® 
result as per the manufacturer’s instructions. 
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2.2.3 Widal Test 
Semi quantitative slide and standard tube method using EUROPATHTM antigen containing S. Typhi O & S. Typhi 
H were performed. Generally antibodies having titers of 1:80 or more were considered clinically and diagnostically 
significant.  
 
2.3 Data Analyses  
The indeterminate results of TUBEX® TF were handled by either doing the retest or by using TUBEX® TF wash 
buffer in accordance to manufacturer’s instructions. The missing data were traced back to laboratory results form 
used initially during results recording. The sample size was based on convenience at two health facilities of our 
study. The data were captured in Microsoft Excel 2016 (Microsoft Corporation, Redmond, United States of 
America) and converted to STATA version 15 (Stata LP, Collage Station, USA). Stata’s diagt was used to 
determine the sensitivity, specificity, positive predictive values (PPVs) and negative predictive values (NPVs). 
Two sided significance level of 5% analyses of the performance of the two rapid diagnostic tests were also done. 
Analyses of 5% and 50% pretest probabilities of background typhoid fever rates were also performed to ensure 
that the results were applicable even in conditions of a few typhoid fever outbreaks – since incidence would be 
higher during outbreaks – and of lower endemicity, given that study patients were selected on the probability of 
having typhoid fever (Keddy et al., 2011). Cohen’s kappa coefficient (k) analysis was used to test the agreement 
of the two sera diagnostic tests against a gold standard. 
 
2.4 Ethical Approval 
This study was approved by the Scientific Ethics and Review Unit at KEMRI (KEMRI/SERU/CMR/P00059/3546). 
Informed consent was obtained from all the research participants where adults obtained their own informed consent 
while parents or guardians consented for the children.  
 
3. Results  
3.1 Participants  
In total, this study was conducted on 152 participants, including 92 participants who had clinically suggestive 
signs and symptoms of typhoid fever. 45 and 15 participants were age and sex matched febrile and healthy controls 
respectively. The diagram showing the flow of participants in the study is as shown in figure 1 below. 
 
Figure 1: Diagram showing flow of participants during the study 
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Headache, abdominal pain and constipation were the main clinical characteristics recorded for our typhoid 
fever cases. Those with slow heart rate and muscle pain were few (Table 1) 
Table1. Characteristics of patients with signs and symptoms for typhoid fever (n=92) 
Characteristics of Patients Values 
Headache 78% 
Abdominal Pain 62% 
Constipation 40% 
Diarrhea 16% 
Vomiting 7% 
Disorientation (Confusion) 4% 
Cough 4% 
Slow heart rate   3% 
Myalgia (sore muscles) and Rash 2% 
Generally, there were a total of 66 males (43.42%) and 86 females (56.58%). Total cases for male were 55 
(59.78%) while female were 37 (40.22%) and corresponding values for febrile controls were 18 (40.00%) males 
and 27 (60%) females and healthy controls were 10 (66.67%) and 5 (33.3%) respectively.  The frequencies of 
cases and controls are as shown in Figure 2-4 below. The participants were of ages between 5-60 years with a 
median age of 36.5 years. 
 
Figure 2: Cases Distribution of Males and Females 
 
Figure 3: Febrile Controls Male and Female Distribution  
 
Figure 4: Healthy Controls Male and Female Distribution 
 
3.2 Blood Culture 
Among 92 clinically suspected typhoid fever cases, 9 (9.78%) were positive for S. Typhi with the highest rate of 
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blood culture positivity for S. Typhi 4 (4.34%) in children between ages 5-12 years, followed by adults 3 (3.26%) 
between ages18-60 years and children aged 13-17 years with 2 (2.17%) consequently. Of this culture positive 
patients, 5 were male (55.50%) while 4 (4.44%) were female. 13 (14.13%) sample cases grew other pathogens 
including Micrococcus, Klebsiella and Bacillus. 21(22.83%) were positive on BACTEC™ 9050 blood culture 
system but did not grow any microorganisms when sub-cultured on blood and MacConkey agar while 49 (53.26%) 
were negative on BACTEC™ 9050 blood culture system after 7 days. In compliance with our eligibility criteria 
no participant was taking any antibiotic upon visiting the health facility and before collection of blood samples. 
 
3.3 Serology 
Among 152 of our research participants, eleven (11.95%) tested positive using TUBEX® TF while 17 (18.48%) 
tested positive using Widal test. Both TUBEX® TF and Widal test were positive in 8/9 (88.89%) of blood culture 
positive cases. Of 83 culture negative cases, TUBEX® TF was positive in 3 (3.61%) and negative in 81 (97.45%) 
while Widal test was positive in 9 (10.84%) and negative in 75 (90.36%). Both TUBEX® TF and Widal test were 
positive in 3 (6.6%) out of the 45 febrile controls. None of the healthy controls were positive by either TUBEX® 
TF or Widal test (Table 2). 
Table 2: Results of TUBEX® TF test and Widal test in different study groups 
Study groups  No. of individual  TUBEX® TF  positive Widal test positive  
Group I  09 08 (88.89)  08 (88.89)  
Group II  83 03 (03.61)  09 (10.84)  
Group III  45  03 (06.67 )  03 (06.67 )  
Group IV  15 00 (00.00)  00 (00.00 )  
Figures in parenthesis indicate percentage.       
Group I - Culture positive typhoid fever cases      
Group II - Culture negative typhoid fever cases 
Group III - Febrile controls 
Group IV - Healthy control. 
3.3.1 Diagnostic tests Evaluation  
The two serological diagnostic techniques, TUBEX® TF and Widal test were evaluated using blood culture as a 
lone reference standard. The sensitivity, specificity, PPV and NPV of the two kits were as shown in table 3 below. 
Controls were from febrile patients and apparently healthy individuals and were considered culture sterile. If all 
the 92 cases with clinically suspected symptoms of typhoid fever were tested with both TUBEX® TF and Widal 
test, sensitivity, specificity, PPVs and NPVs were, 88.9% (95% CI 51.8-99.7), 97.6% (95% CI 91.6-99.7), 80.0%  
(95% CI 44.4-97.5), 98.8% (95% CI 93.4-100.0) and  88.9%  (95% CI 51.8-99.7), 90.4% (95% CI 81.9-95.7), 
50.0%  (95% CI 24.7-75.3),  98.7%  (95% CI 92.9-100.0), respectively. If all the cases and controls were included, 
sensitivity remained constant but PPVs declined. TUBEX® TF had 61.5% (95% CI 31.6-86.1) while Widal test 
had 42.1% (95% CI 20.3-66.5). If neither febrile and healthy controls were separately combined with cases and 
tested, the resulting diagnostic values had no statistical significance as the values were similar as to those recorded 
when cases were tested alone and when the cases were combined with both of these two groups of controls.  
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Table 3: Sensitivity, Specificity and Predictive values of TUBEX® TF test and Widal test using blood culture as a 
reference standard 
 
 Sensitivity % 
(95% CI) 
Specificity % 
(95% CI) 
PPV% (95% 
CI) 
NPV%  
(95% CI) 
Prevalence 
(95% CI) 
Cases 
TUBEX® 
TF 
88.9 (51.8-
99.7) 
97.6 (91.6-99.7) 
80.0 (44.4-
97.5) 
98.8 (93.4-
100.0) 
9.8 (4.6-
17.8) 
 WIDAL 
88.9 (51.8-
99.7) 
90.4 (81.9-95.7) 
50.0 (24.7-
75.3) 
98.7 (92.9-
100.0) 
9.8 (4.6-
17.8) 
Cases+ 
all 
Controls 
TUBEX® 
TF 
88.9 (51.8-
99.7) 
96.5 (92.0-98.9) 
61.5 (31.6-
86.1) 
99.3 (96.1-
100.0)) 
5.9 (2.7-
10.9) 
 WIDAL 
88.9 (51.8-
99.7 ) 
92.3 (86.7-96.1) 
42.1 (20.3-
66.5) 
99.3 (95.9-
100.0) 
5.9 (2.7-
10.9) 
Cases  + 
Sick 
Controls 
TUBEX® 
TF 
88.9 (51.8-
99.7) 
96.1(91.1-98.7) 
61.5 (31.6-
86.1) 
99.2 (95.6-
100.0) 
6.6 (3.0-
12.1) 
 WIDAL 
88.9 (51.8-
99.7) 
91.4 (85.1-95.6) 
42.1 (20.3-
66.5) 
99.2 (95.4-
100.0) 
6.6 (3.0-
12.1) 
Cases + 
Healthy 
Controls 
TUBEX® 
TF 
88.9 (51.8-
99.7) 
98.0 (92.8-99.8) 
80.0 (44.4-
97.5) 
99.0 (94.4-
100.0) 
8.4 (3.9-
15.4) 
 WIDAL 
88.9 (51.8-
99.7) 
91.8 (84.5-96.4) 
50.0 (24.7-
75.3) 
98.9 (94.0-
100.0) 
8.4 (3.9-
15.4) 
CI-Cumulative Intervals, NPV-Negative Predictive Value, PPV- Positive Predictive Value. 
When these results were subjected to 5% pretest probability, PPVs and NPVs for TUBEX® TF and Widal tests 
were 66.0% (95% CI 32.6-88.6),  99.4% (95% CI 96.3-99.9) and 32.7% (95% CI 19.5-49.4), 99.4% (95% CI 96.0-
99.9) respectively. When cases, febrile and apparently healthy controls were subjected to this pretest probability, 
PPVs showed varied decline while NPVs remained constant with little or no variation. When these results were 
further subjected to 50% pretest probability, PPVs rose while NPVs seemed to decline. When cases were subjected 
alone , TUBEX® TF had a PPVs of 97.4% (95% CI 90.2-99.3) and NPVs of 89.8% (95% CI 58.0-98.2) while 
Widal test had 90.2% (95% CI 82.1-94.9) and  89.1% (95% CI 56.1-98.1) respectively. On putting together cases, 
febrile and apparently healthy controls under this pretest probability, there seemed to be minimal to no variation 
on both PPVs and NPVs (Table 4). 
Table 4: Predictive values of TUBEX® TF test and Widal test using blood culture as a reference standard under 
assumed pretest probabilities of 5% and 50% 
  5%  50%  
  PPV% (95% CI) NPV% (95% CI) PPV% (95% CI) NPV% (95% CI) 
Cases 
TUBEX® 
TF 
66.0 (32.6-88.6) 99.4 (96.3-99.9) 97.4 (90.2-99.3) 89.8 (58.0-98.2) 
 WIDAL 32.7 (19.5-49.4) 99.4 (96.0-99.9) 90.2 (82.1-94.9) 89.1 (56.1-98.1) 
Cases + 
all 
Controls 
TUBEX® 
TF 
57.2 (35.4-76.5) 99.4 (96.3-99.9) 96.2 (91.2-98.4) 89.7 (57.8-98.2) 
 WIDAL 37.8 (24.8-52.9) 99.4 (96.1-99.9) 92.0 (86.2-95.5) 89.3 (56.7-98.1) 
Cases + 
Sick 
Controls 
TUBEX® 
TF 
54.5 (33.0-74.5) 99.4 (96.3-99.9) 95.8 (90.3-98.2) 89.6 (57.7-98.2) 
 WIDAL 35.2 (22.8-50.1) 99.4 (96.1-99.9) 91.2 (84.9-95.0) 89.2 (56.4-98.1) 
Cases + 
Healthy 
Controls 
TUBEX® 
TF 
69.6 (36.3-90.2) 99.4 (96.3-99.9) 97.8 (91.6-99.4) 89.8 (58.2-98.2) 
 WIDAL 36.4 (22.1-53.7) 99.4 (96.1-99.9) 91.6 (84.4-95.7) 89.2 (56.5-98.1) 
CI-Cumulative Intervals, NPV-Negative Predictive Value, PPV- Positive Predictive Value. 
On testing the agreement of the two diagnostic tests with gold standard, TUBEX® TF test demonstrated almost 
perfect agreement while Widal test demonstrated substantial agreement (Table 5). 
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Table 5: Agreement of the TUBEX® TF and Widal test with blood culture using Cohen’s kappa coefficient (k) 
Test Blood culture 
Cohen’s k % of Agreement 
TUBEX® TF   0.82 91.19% 
Widal test 0.74 87.13% 
 
4. Discussion  
The diagnosis of typhoid fever is a challenge largely because its signs and symptoms are similar to those of other 
febrile illness (Bhutta ZA, 2006). Isolation of S. Typhi and S. Paratyphi from microbiologic culturing of bone 
marrow is considered a gold standard for the confirmation of typhoid fever (Islam et al., 2106). Considering that 
typhoid fever is very prevalent in very young children in low income and endemic countries, bone marrow culture 
is rarely performed. Therefore, diagnosis of typhoid fever is made principally by blood, stool and urine cultures 
(Bhattacharya et al., 2003), as an alternative to bone marrow culture.  Unfortunately, blood culture has a diagnostic 
yield of 70-75% during the first week of illness and it is affected by antimicrobial use ((Krishna et al., 2011). 
Results require 2-7 days to be available and it entails technical procedures (Bhan et al., 2005). Therefore, rapid 
sera diagnostic tests have been the most preferred methods for diagnosis of typhoid fever in low resource settings 
of endemic countries (Keddy et al., 2011). Widal test has been one of these diagnostic tests and it has been in use 
for over a century in developing countries, but has remained a sera diagnostic test with limited diagnostic utility 
due to low sensitivity, specificity and positive predictive values which changes with geographical areas (Sherwal 
et al., 2004). Sharing of O and H antigens by other Salmonella serotypes and other members of Enterobacteriaceae 
has made the role of Widal test even more controversial in diagnosis of typhoid fever (Parry et al., 2002). TUBEX® 
TF is a new, inexpensive and reliable sera diagnostic test which is still under evaluation and is yet to be 
commercially available. It has been studied in many typhoid endemic countries with reports of significant higher 
sensitivities and specificities. In the present study, we studied TUBEX® TF test in our country for its usefulness in 
diagnosis of typhoid fever in patients presenting in our hospital. We also evaluated Widal test so as to compare its 
performance with that of TUBEX® TF test. 
Among 92 clinically suspected typhoid fever cases in our study, 59.78% were males and 40.22% were females. 
Among them, the isolation of S. Typhi from blood of male patients was 55.5% and 44.44% in females. We had 
more female febrile participants compared to their male counterparts (Fig.3). Fig.4 shows apparently healthy 
endemic zone controls. These findings were in consistent with observation made by Begum (2008) who reported 
60% male and 40% female. These findings also were similar to Roxas and Mendoza (1989) who reported 56% 
male and 44% female cases. Devaranavadagi and Srinivasa (2017) also reported 63.8% male and 36.2% female 
cases. The findings also correlates with the findings reported in Asia. In a study done in Bangladesh comparing 
differences in typhoid fever distribution in age and gender among pediatric patients, the isolation of S. Typhi in 
blood of male patients was 25.7% while for females was 14.9% (Sattar et al., 2016). The high rate of typhoid fever 
infection in males than females, perhaps could due to published observation that places male less adherence to 
hygiene measures whether inside or outside home environment and washing of hands after using public restrooms 
or bathrooms at home, handling food and their greater propensity to eat raw or undercooked foods and at roadside 
locations (Hosoglu et al., 2006; Jeong et al., 2007). For this reason, the hypothesis that sex-linked differences in 
the degree of natural exposure of Peyer’s patches to S. Typhi contribute to high typhoid infection in males than in 
females maybe testable (Khan, 2012). 
The disease affected all ages; however most of the typhoid fever suspected cases came from the age group of 
21-30 years (Fig.2). The high number of cases in this age group may have been partly due to other infections 
having similar clinical symptoms to typhoid fever. In our findings, we found children 5-12 years to be more 
susceptible to typhoid fever with an of isolation rate of S.Typhi of 4.34%. These findings place children of this 
age group in brackets of high risk group. This may due to a lack of immunity transferred by mother’s milk or 
consumption of potable drinking water a common practice in rural/urban settlements (Saha et al., 2003). Despite 
the fact that, typhoid fever is known to be sufficiently severe among children < 5 years old to require outpatient 
and inpatient care (Crump et al., 2004), this study recruited children aged ≥ 5years because very young children 
still have their immune system under development. For this reason their immune antibodies are still weakly 
expressed. Therefore, placing them as part of our participants to evaluate new diagnostic technology could have 
affected the results of our test. This is supported by previous studies that have evidently shown that immunological 
responses and clinical characteristics in young children less than 5 years with S. Typhi bacteremia have to date 
remained poorly characterized (Sattar et al., 2016).  
Our findings were similar to other findings reported by Breiman et al., (2012) done in Kibera slums, Kenya 
where the highest rates of typhoid fever were in children between age group of 5–9 years old (596 per 100,000 
person-years of observation). Our findings were also consistent with the findings reported by studies done in five 
Asian countries, where high rate of isaltion S. Typhi (57%) was from children between the age group of 5-15 years 
(Ochiai et al., 2008). Another study done in Bangladesh among pediatric patients, highest rate of blood culture 
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positivity of S. Typhi was found among children participants within 6-5 years of age (19.14%)(Sattar et al., 2016). 
The similarity of these findings with that from Asian countries is partly due to dense population and severely 
limited options for sanitation and safe water for people who live in overcrowded areas in Africa and in Asia that 
places them at higher risk for typhoid fever (Breiman et al., 2012). These findings proposes immunization 
programs against typhoid fever to be introduced and implemented with an aim of vaccinating younger children 
below 12 years in the first phase. Similarly, this will serve to arrest typhoid infection in other age groups. However, 
since the other young and elderly participants of age group between 13-17 years and 18-60 years respectively 
demonstrated significant percentage of typhoid fever infections, administration of typhoid vaccine booster dose 
should also be done in a potentially endemic population of the disease burden within these age groups (Saha et al., 
2003).  
When we screened 92 febrile patients for S. Typhi by blood culture in our study, 9 (9.78%) constituted 
bacteriologically proven typhoid fever cases and were positive for S. Typhi (Table 2). The remaining 83 patients 
were blood culture negative but with clinically suggestive symptoms of typhoid fever. Our findings recorded a 
little higher prevalence of typhoid fever when compared to previous similar studies done in Kenya. A study on 
typhoid fever incidence in urban settlements and rural area in Kenya reports incidence of typhoid fever in Kibera 
to be 6.4% (Breiman et al., 2012). Another study done in Maina slum, Nyahururu municipality reports a prevalence 
of 6.3% of typhoid fever infections (Nguri, 2011). These two studies were done in Kenya and the differences in 
prevalence between them and our study is noticeable. However, these differences can be explained by two 
hypotheses: (i) The current study was run on a small scale crossectional area and samples were collected within a 
period of six months which may have been the pick season of typhoid infections (Dewan et al., 2013), (ii) Typhoid 
fever prevalence may have rose since when the stated studies were carried out around a decade ago. The association 
of typhoid fever with overcrowding (Kariuki et al., 2006), could prove the second hypothesis since Kenya’s 
population is known to increase by 10 million people every decade, due to improve healthcare systems that increase 
life expectancy and reduces mortality rates.  
In contrast with the data from different geographical areas, the current findings correlate with the findings 
from these areas. A study done in endemic site in Papua New Guinea reported a prevalence of 4% of typhoid fever 
(Arya & Agarwal, 2013). Bhattacharya et al., (2003) reported a prevalence of 2.6% in India. In Egypt, a study 
evaluating Enterocheck WB® test in diagnosis of typhoid fever among Egyptian adults reported a high prevalence 
of 13.6% of typhoid fever (Hamdy et al., 2014). The relatively high prevalence of typhoid fever in this study may 
have been contributed by the fact that, the largest number of the research participants came from the surrounding 
informal settlement with low sanitary hygiene levels. These findings suggest prevalence of typhoid fever to be 
done on a large scale cross sectional study so as to determine the definitive disease burden among population for 
prober planning of control programs 
The performance of diagnostic tests needs to be continuously evaluated to establish if their performance is 
adequate for the diagnostic purposes that are intended. They should however be evaluated under conditions they 
are most likely to be used and in particular human population or clinical setting (Keddy et al., 2011). In our current 
study, we evaluated accuracy of TUBEX® TF rapid diagnostic test and compared its sensitivity with that of Widal 
test. The sensitivity and specificity of TUBEX® TF was comparable to that of Widal test. TUBEX® TF had a 
sensitivity of 88.9% (95% CI: 51.18-99.7) and specificity of 97.6% (95% CI: 91.6-99.7) while Widal test had 
88.89% (95% CI: 51.8-99.7) and 90.4% (95% CI: 81.9-95.7) respectively. However, PPVs of TUBEX® TF and 
Widal test was 80.0 % (95% CI: 44.4-97.5) and 50.00% (95% CI: 24.7-75.3) respectively (Table 3). TUBEX® TF 
demonstrated superior Positive predictive value when compared to Widal test. The low PPV for Widal test was 
clear evidence that the kit was not doing well as compared to the reference standard and also as compared to 
TUBEX® TF. However, the fact that the PPV increases with increasing prevalence while NPV decreases with 
increase in prevalence (Parikh et al., 2008), Widal test could not demonstrate that it is even better than TUBEX® 
TF in our current setting as TUBEX® had higher PPV. Inclusion of controls lowered the PPVs for both TUBEX® 
TF and Widal test and on this regard, both kits performed poorly.  Therefore, the decision to use them at primary 
health setting cannot be recommended in such a case. Nevertheless, the two sera diagnostic tests performed well 
in typhoid confirmed cases in this study. The 9.8% prevalence in our study may not be consistent with the 
prevalence of typhoid fever in other Sub-Saharan African countries. Therefore, when the pretest probability for 
typhoid fever was lowered to 5%, the performance of the two rapid tests declined further suggesting that the two 
rapid tests cannot be of any diagnostic significance in a clinical setting of low endemicity (Table 4). At a 50% 
pretest probability which is higher than the actual fraction of the blood culture positive cases in our study, the 
performance of the two sera diagnostic tests improved greatly suggesting that the tests can be used judicially during 
outbreaks (Keddy et al., 2011). These results were comparable to other results reported in a study carried out 
during the typhoid outbreak in Harare, Zimbabwe where TUBEX® TF was reported to have 100% sensitivity and 
94.12% specificity (Tarupiwa et al., 2015). In another study carried out in two Sub-Saharan countries South Africa 
and United republic of Tanzania, TUBEX® TF had sensitivity of 73.0 % (95% CI: 63.3-83.4) and a specificity of 
69.0% (95% CI: 49.2-84.7) (Keddy et al., 2011). However despite our findings on Semi-quantitative slide and 
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single-tube Widal test being quit promising, it contradicted the findings on these two Sub-Saharan countries as 
these countries reported poor performance. In India, TUBEX® TF test was recommended for the diagnosis of acute 
stage of the disease in a clinical setting with 76% sensitivity and 96-99% specificity (Khanna et al., 2015). These 
results were in agreement with our findings on TUBEX® TF. Blood culture demonstrated a good agreement with 
both TUBEX® TF and Widal test when it was used to form a single predictive value with either of the two index 
tests (Table 5). Therefore, the two tests can be utilized together with blood culture for typhoid diagnosis. We 
performed the TUBEX® TF and Widal tests on unpaired sera though previously it had been reported that sensitivity 
and specificity of a sera diagnostic test for typhoid fever improves with the use of paired sera (House et al., 2005). 
In our setting, it was not possible to use paired sera as we chose to apply the tests under the conditions that are 
found in a clinical practice. In our experience, patients rarely return for outpatient follow-up once treated so that, 
obtaining paired sera in a routine clinical setting is unlikely (Keddy et al., 2011).  
TUBEX® TF test has been evaluated in several other countries with varied level of performance being 
reported. A study in Papua New Guinea evaluated TUBEX® TF using blood culture as gold a standard and it 
demonstrated a high sensitivity of 76% and specificity of 96-99% which was higher than Typhidot and comparable 
to Widal test (Siba et al., 2012). In Egypt, TUBEX® TF had sensitivity of 74.6% and specificity of 75% but it was 
not superior to Widal test as it had a higher result (Bakr et al., 2010). In Asia, the performance of TUBEX® TF in 
India was evaluated and compared with Widal and Typhidot and study reported TUBEX® TF and Typhidot during 
the acute stage of fever is not better than Widal test (Dutta et al., 2006). Moreover, TUBEX® TF produced low 
sensitivity and specificity of 69% and 95% respectively in China and this study concluded that the newer 
serological tests did not offer substantial advantages over the established Widal test (Dong et al., 2007). With 
continued studies to discover better rapid test to diagnose typhoid fever facing various shortcomings, TUBEX® 
TF test has been making a positive progress. One example of this progress is a recent study carried out in Uganda; 
TUBEX® TF was used for epidemiological investigation where a probable typhoid case was defined as a suspected 
case with a positive TUBEX® TF test while blood culture was being used to define a confirmed case (Kabwana et 
al., 2017). 
A sera diagnostic test can be of diagnostic value if its limitations are well known. In endemic areas, the Widal 
test which is an easy inexpensive test with its known shortcomings has been reported to be of diagnostic value in 
unvaccinated individuals where blood culture cannot be obtained especially in developing countries (Khanna et 
al., 2015).  Our study had several limitations. Review of data on recent literature suggests that typhoid fever is 
uncommon, perhaps 100 times or 250 times less common than invasive diseases, and this could been brought about 
by of the use of Widal test that may result in many hundreds of over-treatment episodes for every true case treated 
and may perpetuate the perception that typhoid is common (Mweu et al., 2008: Reddy et al., 2010).). The 9.8% 
prevalence of bacteriologically proven S. Typhi cases may not be consistent with prevalence of typhoid fever in 
other Sub-Saharan countries. Therefore, 5% and 50% pretest probabilities were performed to give results of the 
tests if applied in different areas with low typhoid incidences and during typhoid fever outbreaks that normally 
records high incidences. 
An important limitation for TUBEX® TF test was the absence of cases of other non-typhoidal Salmonella 
such as S. typhimurium and S. enteritidis. Previous studies have shown that TUBEX® TF test may give false 
positive results due to bacteremia caused by S. enteridities because they have 09 antigens (Tam et al., 2008). 
Scoring system of the TUBEX® TF test may have led to operator bias. The scoring system should be standardized 
and operator bias should be removed by taking the readings with the help of machine only (Khanna et al., 2015). 
The results were read by at least 3 independent observers (The PI and 2 qualified technical persons) to validate the 
results. 2 out of 3 concordant results were recorded as either negative or positive with corresponding semi 
quantitative scores using the magnetic color scale.  
Another limitation of this study was that, during an early infection of typhoid fever, immune system may not 
produce enough IgM antibodies to be detected by TUBEX® TF test hence this could give false negative results. 
Additionally, TUBEX® TF test has been designed to detect IgM antibodies; it may detect IgG antibodies when it 
synergistically binds to the antigen coated particles (http://www.idl.se). This may lead to recording of false positive 
results. In our study, there were only three patients who tested positive though their blood cultures tested negative. 
While these patients may have affected our results alittle, it cannot be justified that three positive results on 
TUBEX® TF test were due IgG antibodies synergistically binding to the antigen coated particles alone. 
Widal test had several limitations. The most important of all was lack of demonstration of four-fold rise in 
antibody concentration. Widal test requires acute-and convalescent-phase serum samples collected approximately 
10 days apart where positive result is determined by a 4-fold increase in antibody titer (House et al., 2005). We 
performed the test only at acute stage samples for it was challenging to obtain a convalescent samples consistenly 
in our setting (Andrew et al., 2015). Another limitation for Widal test was difficulties in interpretations of test 
results. Interpretation of results using transparent slides was done on black or white background and bringing them 
close to lighten electric lump for easy visualization of agglutination reaction. 
This study did not include aspiration from bone marrow in our study. Blood culture is known to be less than 
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100% sensitive even in absence of antimicrobial exposure (Andrews and Ryan, 2015). We instead use modern 
blood culture technique BACTEC™ 9050 blood culture system (Becton, Dickinson and Company) to improve 
sensitivity of our blood culture tests by optimizing it (Mirret et al., 2003). This may have limited diagnostic values 
recorded in the study as blood culture was the only sole reference standard. Moreover, antimicrobial susceptibility 
profiles were not perform in this study on the isolates of S. Typhi. This was a limitation because confirmed typhoid 
fever cases could not be ascertained if they were from circulating resistant S. Typhi in the population.  
Our study only covered very selective and small groups of individuals making it relatively small and limiting 
to access exhaustively the impact of socioeconomic status of participants and other factors. This would have served 
to make a more definitive conclusion on the impact of typhoid fever in different economy class of population. 
However, the main objective of our study was to evaluate the effectiveness of the sera diagnostic tests for early 
diagnosis of typhoid fever on hospitalized patients in a clinical setting. In our study TUBEX® TF test showed to 
be significantly better than Widal test and demonstrated shorter turnaround time than both blood culture and Widal 
test. Nonetheless, despite these limitations, this study describes comparison of the newly developed TUBEX® TF 
diagnostic assay and the mostly used Widal test for typhoid fever diagnosis and our results strongly support 
development of the new diagnostic tests. 
 
5. Conclusion 
Typhoid fever in developing countries like Kenya is a major public health problem. The findings from these study 
can be used to deduce the burden of typhoid fever in Kenya and can help in designing, planning and implementing 
immunization programs on typhoid fever targeting specific population at risk especially children below 12 years. 
This study strongly support continued evaluation of performances of the new and old sera diagnostic tests to be 
done on regular basis. This will play a critical role in diagnosis, management of antimicrobial resistance and 
treatment of typhoid fever. TUBEX® TF test proved superior to Widal test when blood culture was used as a 
reference standard. However, these results should be further confirmed by using multiple reference standards like 
molecular and ELISA and carried out on large scale cross-sectional studies with varied prevalence of typhoid fever 
in the population. Our findings showed that either TUBEX® TF or Widal test can be used to make a single 
predictive value with blood culture to diagnose typhoid fever. Performance of TUBEX® TF was promising unlike 
that of Widal test. However, none of the two sera diagnostic tests can justifiably be used alone in a clinical set up 
to diagnose typhoid fever. With increasing need to introduce typhoid vaccine as a means of managing typhoid 
infections, surveillance will be critical in providing the guidance for the deployment of vaccines. Diagnostic speed 
may be sacrificed but accuracy will be critical (Andrew et al., 2015). Therefore, there is an urgent need for a highly 
sensitive and specific diagnostic technique to be developed for the purposes of surveillance, correct diagnosis and 
effective treatment of typhoid fever. 
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